Show results for
Refine by
Coronary Stent Suppliers Serving Germany
31 companies found
based inHechingen, GERMANY
Bentley is an international medical technology company with headquarters in the South of Germany. At Bentley we are passionate about the development, manufacture and marketing of innovative products for the minimally invasive treatment of vascular ...
This extraordinary product combines a highly flexible one-layer stent graft with a low-profile balloon catheter to offer an unrivalled small guiding catheter compatibility. The cobalt-chrome stent platform is ...
based inBrunswick, AUSTRALIA
Avania is an integrated global, full-service CRO with specialized expertise in medical device, novel technology, and combination products. They advance products from feasibility all the way through post-approval trials in analytics, clinical trials, ...
based inLeeds, UNITED KINGDOM
Founded in 2009, Leeds-based Arterius is developing a next-generation bioresorbable cardiovascular scaffold (stent) with an emerging market-leading clinical profile. The founding directors have significant experience in the development of medical ...
based inWinsen, GERMANY
QualiMed was found in 1997 as an OEM manufacturer for implantable medical devices with a focus on the development and regulatory approval of coronary stents and their respective delivery devices. Later the business was expanded to peripheral ...
The MAGMA Rapamycin-Eluting Coronary Stent System is the first carbonized stent (Inert Carbon Technology) with a completely biodegradable polymer coating which contains Rapamycin (Rapasorb™) ...
based inMiami Lakes, FLORIDA (USA)
Cordis is an independent, customer-focused provider of interventional cardiovascular technologies. During our 60-year history we’ve established a legacy of pioneering breakthrough technologies, including the first guiding catheters and coronary drug ...
based inMilpitas, CALIFORNIA (USA)
Elixir Medical is committed to transforming care of patients with heart and vascular disease through innovation. Since 2005, the company has continually sought to improve the treatment of vascular disease with: Drug-eluting coronary stent systems ...
The DESyne X2 Novolimus Eluting Coronary Stent System is a low-profile DES with high flexibility and exceptional deliverability. The ultra-thin design of its stent and polymer coating, with no ...
based inWinsen, GERMANY
amg International GmbH develops, manufactures and sells on a world-wide basis stents, stent implantation systems and balloon catheters as well as auxiliary products such as guide wires and inflation devices, which are used primarily in the field of ...
The ITRIXII Sirolimus-Eluting Coronary Stent Implantation System is the first carbonized stent (Inert Carbon Technology) with a completely biodegradable polymer coating which contains Sirolimus ...
based inShanghai, CHINA
MicroPort is a global medical devices company, founded on the belief that every person has the right to high quality medical treatments and to live longer and healthier lives. All our solutions are designed to deliver on that belief. Our close ...
CoCr Stent Platform. Reliable durable polymer-Styrene Butylenes Styrene. Uniform sine wave design provides uniform support strength and ...
based inHeilbronn, GERMANY
seleon gmbh has been developing and producing complex equipment for customers in the medical technology field since 1998, growing into a leading medical technology service provider. We develop individual solutions in partnership with our customers ...
Several steps can be completed in one with the device. The protective cap is removed from the stent with the operation of the lever, and at the same time, the drug is applied and dried with sterile ...
based inMulhouse, FRANCE
CellProthera is a biotech company, incorporated in April 2008, and intended for the development, registration and marketing of innovative therapeutic solutions for the regeneration of organs damaged by disease or trauma from autologous blood ...
The unique therapeutic approach proposed by CellProthera is protected by various patents. It requires a simple blood sampling best performed within 2 weeks following a severe AMI. The sampling occurs after a treatment period using GCSF in order to ...
based inAwans, BELGIUM
Miracor Medical is a European medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. Miracor develops and studies the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System ...
based inLivermore, CALIFORNIA (USA)
Advanced Bifurcation Systems has disruptive technology for left main heart disease, stenting coronary arteries at their branch points. This platform is a paradigm shift in interventional cardiology. The ABS platform is protected by more than 36 ...
based inWinsen, GERMANY
Stron Medical was launched in 2010 as a product line of QualiMed. With an impressive range of innovative products and a committed team of sales professionals, Stron Medical provides end-to-end solutions within Germany. QualiMed was found in 1997 as ...
The GALAXY Rapamycin-Eluting Coronary Stent System is the first carbonized stent (Inert Carbon Technology) with a completely biodegradable polymer coating which contains Rapamycin (Rapasorb™) ...
based inSurat, INDIA
SMT is a global medical device company committed to making advance medical technologies accessible to everyone around the world. With a presence in over 69 countries, SMT has achieved recognition from the Government of India for its tremendous ...
Supraflex Cruz is an amalgamation of the best-in-class features like lowest strut thickness (60 μm), biodegradable polymer and offers an extensive size ...
based inSeoul, SOUTH KOREA
CG Bio Inc. is a total healthcare provider with a goal of enhancing the quality of life by offering range of innovative solutions for the spectrum of spinal disorders and wound management. Through extensive research activity, CG Bio is a leading ...
based inBonn, GERMANY
CARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercializes innovative medical devices such as the new generation of DCB and drug-eluting stents for the treatment of coronary and peripheral artery disease. The ...
The treatment of the heart requires superior medical device safety with predictable clinical efficacy. ...
based inErlangen, GERMANY
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. We expand ...
The purpose of the study was to collect data on the routine patterns of use, safety and effectiveness, including the clinical and technical performance of the CorPath 200 System, in the delivery and manipulation of coronary ...
based inFranklin Lakes, NEW JERSEY (USA)
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research ...
Tepha is developing fully absorbable stents and coatings made from TephaFLEX® material. This could allow for local drug elution while leaving no permanent residual polymer, which might address the issue of late stent thrombosis with current ...
based inBaoji City, CHINA
TopTiTech is located in the east area of Baoji High-tech Industrial Development Zone, which is well-known as “Titanium Valley”in China. It is a technology-based private enterprise specializing in the production, research and development and sales of ...
1. Capillary effect; 2. Corrosion Resistance; 3. Strength and Lightweight; 4. Biocompatibility. ...
based inHechingen, GERMANY
Founded in 2000 in Germany, Translumina is a global interventional cardiovascular devices company with an ambition to deliver world-class products and services. We are a fully integrated product development and manufacturing company with ...
The Translumina Yukon drug-eluting stent product family, coated with Rapamycin (Sirolimus) and the biodegradable component polylactide (PLA), has an excellent history of pre-clinical and long-term clinical ...